suspicious timing – Libero Quotidiano

Toh, what a case. It turns out in fact that the CEO of Pfizer, the US giant that announced it had developed a “90% effective” coronavirus vaccine, on the day of the announcement sold 132,508 shares of the group which he held, for a value of 5.56 million dollars. To close the deal is Albert Bourla, a news that emerged in the last few hours from the mandatory communications on managers and on the sale of shares on the Stock Exchange Wall Street. In short, the manager – as reported by the Corriere della Sera – he sold 62% of the shares in the group he leads. Suspicious timing, very suspicious. Pfizer however defended Bourla by explaining that the sale of the shares it had been decided on August 19th and it was part of a stock sale plan conditional on the stock reaching a certain value, reached right after the announcement. In short, in any case, the mechanism seems well thought out: the flare-up on the stock market is discounted in the event that the vaccine was found and announced.

According to figures released by the SEC, the American stock exchange authority, Bourla sold 132,508 shares at $ 41.94 per share. The disposal of these shares is part of Dr. Bourla’s personal financial planning and a pre-established plan, which allows, under the rules of the SEC, the main shareholders and employees of listed companies to exchange a predetermined number of shares in a predetermined time “, Pfizer cut short. Yet, some suspicions remain …